Geladari, E.V.; Vallianou, N.G.; Margellou, E.; Kounatidis, D.; Sevastianos, V.; Alexopoulou, A. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now? Gastroenterol. Insights2024, 15, 156-167.
Geladari, E.V.; Vallianou, N.G.; Margellou, E.; Kounatidis, D.; Sevastianos, V.; Alexopoulou, A. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now? Gastroenterol. Insights 2024, 15, 156-167.
Geladari, E.V.; Vallianou, N.G.; Margellou, E.; Kounatidis, D.; Sevastianos, V.; Alexopoulou, A. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now? Gastroenterol. Insights2024, 15, 156-167.
Geladari, E.V.; Vallianou, N.G.; Margellou, E.; Kounatidis, D.; Sevastianos, V.; Alexopoulou, A. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now? Gastroenterol. Insights 2024, 15, 156-167.
Abstract
Benign recurrent intrahepatic cholestasis (BRIC) is a rare genetic cause of cholestasis. It is considered as part of inherited intrahepatic cholestasis syndromes, such as progressive familial intrahepatic cholestasis (PFIC), and intrahepatic cholestasis of pregnancy. BRIC is presented in infancy or in early adulthood. It is characterized by exacerbations and remissions of jaundice with accompanying intense itching, lasting from weeks to years throughout lifetime. Normal gamma-glutamyl transferase (GGT) is a characteristic laboratory finding. Contrary to PFIC, which may progress to cirrhosis, BRIC does not progress to chronic liver disease or cirrhosis. However, incessant episodes of cholestasis result in marked reduction in quality of life and distinct mutations increase the risk of hepatobiliary malignancy. In intervals between the exacerbations, the histological findings of centrilobular cholestasis together with the abnormal laboratory parameters return to normal. In this context, liver biopsy might be avoided. In this review, we will focus on the genetic aspects of BRIC, its pathophysiology, clinical presentation, and prognosis of this autosomal recessive genetically determined cholestatic disorder. Moreover, triggering factors as well as treatment options will be further elucidated.
Medicine and Pharmacology, Gastroenterology and Hepatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
